EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19 | -99.0% | 21,271 | -98.7% | 0.00% | -100.0% |
| Q4 2022 | $1,907 | -100.0% | 1,615,447 | +206.7% | 0.00% | -75.0% |
| Q3 2022 | $3,966,000 | +19.4% | 526,767 | -0.1% | 0.00% | +100.0% |
| Q2 2022 | $3,321,000 | -20.8% | 527,056 | +4.3% | 0.00% | -33.3% |
| Q1 2022 | $4,193,000 | +937.9% | 505,197 | +550.1% | 0.00% | – |
| Q4 2021 | $404,000 | +364.4% | 77,716 | +493.8% | 0.00% | – |
| Q3 2021 | $87,000 | +24.3% | 13,089 | +57.6% | 0.00% | – |
| Q2 2021 | $70,000 | -70.2% | 8,307 | -68.7% | 0.00% | – |
| Q1 2021 | $235,000 | -71.1% | 26,566 | -59.8% | 0.00% | – |
| Q4 2020 | $814,000 | +15.6% | 66,124 | -23.6% | 0.00% | – |
| Q3 2020 | $704,000 | +33.6% | 86,535 | +57.4% | 0.00% | – |
| Q2 2020 | $527,000 | +328.5% | 54,963 | +207.3% | 0.00% | – |
| Q1 2020 | $123,000 | -67.2% | 17,884 | -29.1% | 0.00% | – |
| Q4 2019 | $375,000 | +164.1% | 25,220 | +81.0% | 0.00% | – |
| Q3 2019 | $142,000 | -24.1% | 13,934 | -20.9% | 0.00% | – |
| Q2 2019 | $187,000 | -81.6% | 17,606 | -75.8% | 0.00% | -100.0% |
| Q1 2019 | $1,016,000 | +15.3% | 72,697 | -16.1% | 0.00% | 0.0% |
| Q4 2018 | $881,000 | – | 86,646 | +2166050.0% | 0.00% | – |
| Q3 2018 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 4 | -99.9% | 0.00% | – |
| Q4 2017 | $78,000 | – | 5,604 | +140000.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 4 | -99.9% | 0.00% | – |
| Q2 2017 | $56,000 | +700.0% | 7,104 | +1033.0% | 0.00% | – |
| Q1 2017 | $7,000 | – | 627 | +15575.0% | 0.00% | – |
| Q4 2016 | $0 | – | 4 | -86.7% | 0.00% | – |
| Q3 2016 | $0 | – | 30 | +650.0% | 0.00% | – |
| Q2 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |